Dan Feng
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases Metastatic Colorectal Cancer, Liver Metastases | Phase 1 / Phase 2 | 2026-03-15 |
| Recruiting | Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 1 / Phase 2 | 2025-12-01 |